Corticosteroids Not Superior to Placebo for Add-On Treatment of Bacterial Keratitis

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 28, 2025.

via HealthDay

MONDAY, July 28, 2025 -- For the treatment of bacterial keratitis, adjunctive corticosteroids are not superior to placebo and adjunctive corneal cross-linking (CXL) is associated with increased scar size, according to a study published online July 24 in JAMA Ophthalmology.

N. Venkatesh Prajna, D.O., from the Aravind Eye Care System in Madurai, India, and colleagues examined the benefit of adjunctive topical difluprednate and CXL with riboflavin in addition to topical antibiotics in a placebo-controlled trial involving participants with smear- and/or culture-positive bacterial corneal ulcers with Snellen visual acuity of 20/40 or worse. Two hundred eighty participants were enrolled and randomly assigned to topical moxifloxacin + topical placebo + sham CXL (standard-therapy arm) versus topical moxifloxacin + difluprednate + sham CXL (early-steroid arm) versus topical moxifloxacin + difluprednate + CXL (CXL arm).

The researchers observed no significant difference in six-month visual acuity with adjunctive topical steroids versus placebo or with adjunctive CXL and topical steroids versus topical steroids alone. After controlling for baseline infiltrate and/or scar size, adjunctive topical corticosteroids did not improve scar size at six months, while CXL plus corticosteroids increased scar size compared with steroids alone. After controlling for infiltrate depth, the risk for perforation or the need for therapeutic penetrating keratoplasty was lower, but not significantly so, in the early-steroid arm and in the CXL arm.

"Adjunctive topical corticosteroids were not superior to placebo, and adjunctive CXL had increased scar size with more pain, suggesting that these alternative therapies, on average, may not be superior to topical moxifloxacin monotherapy for treatment of bacterial keratitis," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-29 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords